Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.
Ian M McElreeRyan L SteinbergAlex C MartinJordan RichardsSarah L MottPaul T GellhausKenneth G NeppleMichael A O'DonnellVignesh T PackiamPublished in: The Journal of urology (2022)
Gem/Doce is an effective and well-tolerated therapy for BCG-naïve NMIBC. Further investigation is warranted.